Noteworthy phenomena and emerging trends in illegal drugs (2010-2011)

 

Noteworthy phenomena and emerging trends in illegal drugs (2010-2011)

Tendances n° 78, OFDT, 6 p.
February 2012

The twelfth edition of the TREND (Emerging Trends and New Drugs) scheme took place in 2010. The main goal of TREND, established by the OFDT (French Monitoring Centre for Drugs and Drug Addiction) in 1999, is to identify and describe changes in trends and emerging phenomena in illegal or misused psychotropic substances. This issue of Tendances will also include the first set of data available on the first half of 2011, as provided by the seven local coordinating entities (Bordeaux, Lille, Marseille, Metz, Paris, Rennes and Toulouse).

This issue of Tendances is divided into three main sections. The first will examine the only major emerging phenomenon identified in 2010, the second will be devoted to describing recent trends and the third will examine changes in the use of the different substances monitored by the TREND scheme.

Authors :
Agnès Cadet-Taïrou, Michel Gandilhon, Emmanuel Lahaie

Download the PDF file (138 Ko)

 

 

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.